DSM-Firmenich: How To Evaluate A Chemical Giant (OTCMKTS:DSFIY)
· seekingalpha.com
Following the divestment of its volatile animal nutrition segment, DSM-Firmenich now boasts a robust A-rated balance sheet. Read why DSFIY stock is a Buy.
Sometimes you find companies that go well outside of the typical "mould" of what companies are "supposed" to be. In this article, I'll look at a company that ma...